Diabetics on Januvia, Byetta at risk for dangerous pancreatic inflammation, researchers find

Share this article:
People who take diabetes medications Januvia and Byetta are at a significantly elevated risk of a painful and potentially dangerous pancreatic inflammation, according to a recently published study.

Johns Hopkins University School of Medicine researchers looked at 1,269 people who took at least one prescription diabetes drug between 2005-2008, comparing them to a control group of 1,269 diabetics who did not take a prescription drug to treat the condition during that period.

People who took glucagon-like peptide-1-based drugs such as Januvia and Byetta were twice as likely as other diabetics of being hospitalized with pancreatitis within 60 days of starting a course of drug treatment.

Pancreatitis is inflammation of the pancreas that can be fatal if left untreated. The millions of patients on Januvia and Byetta means long-term care providers should be alert to the symptoms of pancreatitis, the researchers cautioned. Symptoms include abdominal pain, nausea and persistent vomiting.

The study results appear in the online edition of the journal JAMA Internal Medicine.

Share this article:

More in News

Hospitals slap the government with lawsuits over 'two-midnight' policy to reduce observation stays

Hospitals slap the government with lawsuits over 'two-midnight' ...

The American Hospital Association and other hospital groups have sued the federal government over the so-called "two-midnight rule," which was designed in part to ease access to skilled nursing services. ...

Government would pay seniors to create advanced directives under Senate bill

Medicare beneficiaries would be paid to create advance directives and store them in an easy-access system if a recently proposed Senate bill were to become law.

MS patients less tense and pessimistic in nursing homes than at home, ...

Nursing home residents with severe multiple sclerosis report being less tense and pessimistic than similar individuals receiving care at home, according to recently published research findings.